clinical trial · NCT07269769
A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD
Tasly Pharmaceutical Group Co., Ltd·phase3·not yet recruiting·n = 450
AMDSanhuang Jingshiming/Pills placebo
brief summary
The purpose of the TSL-TCM-SHJSMW-Ⅲ study is to study the efficacy and safety of Sanhuang Jingshiming Pills in subjects with Neovascular Age-Related Macular Degeneration.
started
Apr 30, 2026
primary completion
Dec 31, 2031
completion
Dec 31, 2031
last updated
Apr 8, 2026
official title
A Phase III , Randomized, Double-blind, Placebo-Controlled, Ranibizumab Injection Loading, Multicenter Clinical Trial Comparing the Efficacy and Safety of Sanhuang Jingshiming Pills in Subjects With nAMD
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol